Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報

◆英語タイトル:Spire Inc (SR) - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA904C8753
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spire Inc (Spire), formerly Laclede Group, Inc., is a public utility, which carries out the sale, marketing and retail distribution of natural gas. It also markets natural gas and related activities on a non-regulated basis. The company also conducts transportation of liquid propane; real estate development and compression of natural gas. It also offers propane storage and related services to third parties. The company conducts utility operations through main and related service lines, regulation and odorization facilities, customer meters in Missouri and Alabama. It purchases natural gas through future contracts and serves customers primarily in the central US. Spire is headquartered in St Louis, Missouri, the US.

Spire Inc (SR) – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Spire Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Spire Inc, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Spire Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Spire Inc, Oil & Gas, Deals By Sector, 2012 to YTD 2018 8
Spire Inc, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Spire Inc, Oil & Gas, Deal Details 10
Equity Offering 10
Spire Completes Public Offering Of Shares For US$158.1 Million 10
Spire Completes Public Offering Of Shares For US$137.8 Million 12
Debt Offering 14
Spire Completes Private Placement Of 3.92% Senior Notes, Due 2048 For US$45 Million 14
Spire Completes Private Placement Of 4.02% Senior Notes, Due 2058 For US$30 Million 15
Spire Missouri Completes Private Placement Of 3.68% Bonds, Due 2032 For US$50 Million 16
Laclede Gas Completes Private Placement Of 4.23% Bonds, Due 2047 For US$70 Million 17
Spire Missouri Completes Private Placement Of 4.38% Bonds, Due 2057 For US$50 Million 18
Spire Completes Private Placement Of 3.93% Senior Notes, Due 2027 For US$100 Million 19
Spire Completes Public Offering Of 3.543% Senior Notes, Due 2024 For US$6.3 Million 20
Spire Completes Private Placement Of 3.13% Senior Unsecured Notes, Due 2026 For US$130 Million 21
Spire Completes Private Placement Of 2.52% Senior Unsecured Notes, Due 2021 For US$35 Million 22
Acquisition 23
Spire Acquires 80% Interest In Ryckman Creek Resources For US$24.8 Million 23
Spire Completes Acquisition Of EnergySouth From Sempra U.S. Gas & Power For US$344 Million 24
Laclede Gas Completes Acquisition Of Missouri Gas Energy From Southern Union For US$975 Million 26
Sempra U.S. Gas Completes Acquisition Of Willmut Gas For US$29 Million 28
Spire Inc – Key Competitors 29
Spire Inc – Key Employees 30
Spire Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Financial Announcements 33
Aug 02, 2018: Spire reports third quarter results 33
Feb 01, 2018: Spire Reports First Quarter Results 37
Nov 15, 2017: Spire Reports 2017 Results 40
Aug 02, 2017: Spire Reports Third Quarter Results 2017 44
May 03, 2017: Spire Reports Second Quarter Results 48
Feb 01, 2017: Spire Reports Q1 Fiscal 2017 Results 53
Other Significant Developments 56
Aug 03, 2018: Spire STL pipeline receives federal approval 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Spire Inc, Oil & Gas, Key Facts, 2017 2
Spire Inc, Oil & Gas, Deals Summary, 2012 to YTD 2018 2
Spire Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Spire Inc, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Spire Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Spire Inc, Deals By Sector, 2012 to YTD 2018 8
Spire Inc, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Spire Completes Public Offering Of Shares For US$158.1 Million 10
Spire Completes Public Offering Of Shares For US$137.8 Million 12
Spire Completes Private Placement Of 3.92% Senior Notes, Due 2048 For US$45 Million 14
Spire Completes Private Placement Of 4.02% Senior Notes, Due 2058 For US$30 Million 15
Spire Missouri Completes Private Placement Of 3.68% Bonds, Due 2032 For US$50 Million 16
Laclede Gas Completes Private Placement Of 4.23% Bonds, Due 2047 For US$70 Million 17
Spire Missouri Completes Private Placement Of 4.38% Bonds, Due 2057 For US$50 Million 18
Spire Completes Private Placement Of 3.93% Senior Notes, Due 2027 For US$100 Million 19
Spire Completes Public Offering Of 3.543% Senior Notes, Due 2024 For US$6.3 Million 20
Spire Completes Private Placement Of 3.13% Senior Unsecured Notes, Due 2026 For US$130 Million 21
Spire Completes Private Placement Of 2.52% Senior Unsecured Notes, Due 2021 For US$35 Million 22
Spire Acquires 80% Interest In Ryckman Creek Resources For US$24.8 Million 23
Spire Completes Acquisition Of EnergySouth From Sempra U.S. Gas & Power For US$344 Million 24
Laclede Gas Completes Acquisition Of Missouri Gas Energy From Southern Union For US$975 Million 26
Sempra U.S. Gas Completes Acquisition Of Willmut Gas For US$29 Million 28
Spire Inc, Key Competitors 29
Spire Inc, Key Employees 30
Spire Inc, Subsidiaries 31

List of Figures
Spire Inc, Oil & Gas, Deals by Type, 2012 to YTD 2018 2
Spire Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 2
Spire Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 2
Spire Inc, Oil & Gas, Deals By Sector, 2012 to YTD 2018 2
Spire Inc, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Spire Inc, Oil & Gas, Deals by Type, 2012 to YTD 2018 6
Spire Inc, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Spire Inc, Oil & Gas, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marshall Aerospace and Defence Group:企業の戦略・SWOT・財務情報
    Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report Summary Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Venoco, LLC-石油・ガス分野:企業M&A・提携分析
    Summary Venoco, LLC (Venoco), formerly known as Venoco, Inc., is an independent energy company. It carries out acquisition, exploration, exploitation and development of oil and natural gas properties. The company’s major onshore and offshore properties are located in Southern California. Venoco offs …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bourbon Corporation:企業の戦略・SWOT・財務情報
    Bourbon Corporation - Strategy, SWOT and Corporate Finance Report Summary Bourbon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oneness Biotech Co Ltd (4743):製薬・医療:M&Aディール及び事業提携情報
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purific …
  • Ganymed Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Ganymed Pharmaceuticals AG (Ganymed) is a biopharmaceutical company that manufactures and distributes monoclonal antibodies for the treatment of solid cancers. The company conducts clinical trials to manufacture various drug candidates. It also offers antibody cancer drugs and IMABS for mono …
  • Penn United Technologies, Inc.:企業の戦略・SWOT・財務情報
    Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Transat A.T. Inc:戦略・SWOT・企業財務分析
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Methanex Corp (MX):企業の財務・戦略的SWOT分析
    Methanex Corp (MX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enerflex Ltd (EFX):企業の財務・戦略的SWOT分析
    Enerflex Ltd (EFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Haitong Securities Co., Ltd.
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Zai Lab Ltd (ZLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Zai Lab Ltd (Zai Lab) is a biopharmaceutical company that discovers, develops and manufactures transformative medicines for cancer, autoimmune and infectious diseases. The company’s pipeline products include ZL-2306, ZL-2401, FPA144, EXT2514SUL, ZL-2301, ZL-3101, ZL-2302 and ZL-1101. It deve …
  • Green Cross Cell Corp (031390):企業の財務・戦略的SWOT分析
    Green Cross Cell Corp (031390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Forrester Research, Inc.
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Georgia-Pacific LLC:企業の戦略・SWOT・財務分析
    Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report Summary Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cascadian Therapeutics Inc (CASC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …
  • leon-nanodrugs GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Leon-Nanodrugs GmbH (Leon-Nanodrugs) is a drug development company that discovers and develops nanotechnology based drug delivery systems. The company develops oral and parenteral products. Its products portfolio includes nanoparticles and drug-delivery-systems such as functionalized multila …
  • Infant Bacterial Therapeutics AB (IBT B)-製薬・医療分野:企業M&A・提携分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆